Colorectal Endoscopic Submucosal Dissection: An Update on Best Practice
Tara Keihanian,Mohamed O Othman
DOI: https://doi.org/10.2147/CEG.S249869
2021-08-03
Clinical and Experimental Gastroenterology
Abstract:Tara Keihanian, 1 Mohamed O Othman 2 1 Division of Gastroenterology, University of Miami Miller School of Medicine, Miami, FL, USA; 2 Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, TX, USA Correspondence: Mohamed O Othman Gastroenterology and Hepatology Section, Baylor College of Medicine, 7200 Cambridge St., 8th Floor, Suite 8B, Houston, TX, 77030, USA Email Endoscopic submucosal dissection (ESD) is a method of en-bloc resection of neoplastic colorectal lesions which is less invasive compared to surgical resection. Lesion stratification, architecture recognition and estimation of depth of invasion are crucial for patient selection. Expert endoscopists have integrated a variety of classification systems including Paris, lateral spreading tumor (LST), narrow band imaging (NBI), international colorectal endoscopic (NICE) and Japanese NBI expert team (JNET) in their day-to-day practice to enhance lesion detection accuracy. Major societies recommend ESD for LST-non granular (NG), Kudo-VI type, large depressed and protruded colonic lesions with shallow submucosal invasion. Chance of submucosal invasion enhances with increased depth as well as tumor location and size. In comparison to endoscopic mucosal resection (EMR), ESD has a lowerl recurrence rate and higher curative resection rate, making it superior for larger colonic lesions management. Major complications such as bleeding and perforation could be seen in up to 11% and 16% of patients, respectively. In major Western countries, performing ESD is challenging due to limited number of expert providers, lack of insurance coverage, and unique patient characteristics such as higher BMI and higher percentage of previously manipulated lesions. Keywords: endoscopic submucosal dissection, colonic neoplasm, endoscopic mucosal resection Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are two methods for the removal of pre-malignant and early malignant colonic lesions. EMR is usually not successful for en-bloc removal of lesions greater than 20 mm in diameter; piecemeal resection of larger lesions has been shown to correlate with a higher recurrence rate in comparison to ESD. 1 Conventional EMRs usually result in endoscopic piecemeal mucosal resection of large lateral spreading tumors ≥20 mm, with reports of local recurrence rates ranging from 7.4 to 17%. 2 The concept of ESD was first introduced in the late 1990s for en-bloc removal of superficial gastric malignancies in Japan. 2 Considering the greater recurrence rate of larger lesions after EMR, ESD is preferred for lesions with limited submucosal invasion and particularly if the lesions are larger than 30 mm. 3 ESD allows for exact histopathological evaluation of the specimen margin, enhancing its utility and avoiding further unnecessary surgical interventions. The adoption of ESD worldwide for the treatment of early-stage colorectal cancers promoted various societies and gastrointestinal associations to publish guidelines and recommendations to standardize the practice. One of the first updated guidelines was released by the Japanese Gastroenterological Endoscopy Society (JGES) in 2015. According to the JGES, indications for ESD include: 4 The European Society of Gastrointestinal Endoscopy (ESGE) also released their recommendations on the same year, focusing on ESD application in Western populations. Their recommendations were similar to the JGES guideline, advising ESD for colorectal lesions with depressed morphology and irregular or nongranular surface pattern, particularly if the lesions are larger than 20 mm 3 . The guideline still referred to surgery for gold standard treatment for lesions IIa + c, IIc, III, non-lifting lesions, or LST-NG > 20mm, with the exception of rectal lesions, however. 3 Most recently, the American Gastroenterology Association (AGA) clinical practice update was released in 2019, recommending ESD for colonic lesions with Kudo V-type pit pattern, depressed component (Paris 0–IIc), complex morphology (0–Is or 0–IIa+Is), rectosigmoid location, nongranular LST (adenomas) 20 mm in size, granular LST (adenomas) > or =30 mm in size, and residual or recurrent colorectal adenomas. 5 For lesions with unfavorable features after resection, further surgical intervention might be necessary. The most recently published Korean practice guideline, 2020, similar to the Japanese clinical guideline in 2015, acknowledged that the presence of poor histopathological types (poorly differentiated adenocarcinoma, signet ring cell carcinoma, mucinous carc -Abstract Truncated-